WMS Partners’s Fortress Biotech FBIO Stock Holding History

WMS Partners’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-775	Closed	-$3.38K	–	257
2023 Q3	$3.38K	Hold	775	–	–	﹤0.01%	258
2023 Q2	$6.39K	Hold	775	–	–	﹤0.01%	286
2023 Q1	$9.53K	Hold	775	–	–	﹤0.01%	275
2022 Q4	$7.61K	Hold	775	–	–	﹤0.01%	272
2022 Q3	$10K	Hold	775	–	–	﹤0.01%	259
2022 Q2	$10K	Hold	775	–	–	﹤0.01%	260
2022 Q1	$16K	Hold	775	–	–	﹤0.01%	267
2021 Q4	$29K	Hold	775	–	–	0.01%	222
2021 Q3	$37K	Hold	775	–	–	0.01%	275
2021 Q2	$41K	Hold	775	–	–	0.01%	259
2021 Q1	$41K	Hold	775	–	–	0.01%	223
2020 Q4	$37K	Buy	+775	New	+$33.6K	0.01%	236

Other funds holding FBIO

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

WMS Partners's FBIO Position: Q4 2023 in Review

WMS Partners sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 775 shares — an estimated $3.38K sold.

WMS Partners first reported a position in FBIO in Q4 2020 and held it in 12 quarters. The position peaked at $41K in Q2 2021. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

WMS Partners reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
WMS Partners sold 775 Fortress Biotech shares in Q4 2023, an estimated $3.38K.
WMS Partners first reported a position in Fortress Biotech in Q4 2020 and held it in 12 quarters.
WMS Partners's Fortress Biotech position peaked at $41K in Q2 2021.
42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on WMS Partners's 13F filing for Q4 2023, filed 12 Feb 2024.